naltrexone and risperidone

naltrexone has been researched along with risperidone in 18 studies

Research

Studies (18)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (5.56)18.2507
2000's6 (33.33)29.6817
2010's11 (61.11)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Topliss, JG; Yoshida, F1
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL1
Andricopulo, AD; Moda, TL; Montanari, CA1
Lombardo, F; Obach, RS; Waters, NJ1
Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ1
Ekins, S; Williams, AJ; Xu, JJ1
Alelyunas, YW; Bui, K; Empfield, JR; McCarthy, D; Pelosi-Kilby, L; Shen, C; Spreen, RC1
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ1
Dalvie, D; Loi, CM; Smith, DA1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Blatt, SD; Botash, AS; Church, CC; Jean-Louis, F; Meguid, V; Siripornsawan, MP; Weinberger, HL1
Hunsinger, DM; Nguyen, T; Raffa, RB; Zebraski, SE1
Dove, D; McPheeters, ML; Sathe, NA; Taylor, JL; Veenstra-VanderWeele, J; Warren, Z1
Banga, A; Connor, DF1
Oravecz, R; Štuhec, M1
Findling, RL; Ji, NY1

Reviews

5 review(s) available for naltrexone and risperidone

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016
Sudden infant death syndrome, child sexual abuse, and child development.
    Current opinion in pediatrics, 1999, Volume: 11, Issue:2

    Topics: Autistic Disorder; Child; Child Abuse, Sexual; Child, Preschool; Condylomata Acuminata; Fluoxetine; Humans; Infant; Infant, Newborn; Naltrexone; Narcotic Antagonists; Papillomaviridae; Papillomavirus Infections; Risperidone; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Sudden Infant Death

1999
Is there a basis for novel pharmacotherapy of autism?
    Life sciences, 2000, Aug-25, Volume: 67, Issue:14

    Topics: Amino Acid Sequence; Animals; Antipsychotic Agents; Autistic Disorder; Buspirone; Dietary Supplements; Humans; Immunoglobulins, Intravenous; Molecular Sequence Data; Naltrexone; Narcotic Antagonists; Risperidone; Secretin; Selective Serotonin Reuptake Inhibitors; Serotonin Receptor Agonists

2000
Medications for adolescents and young adults with autism spectrum disorders: a systematic review.
    Pediatrics, 2012, Volume: 130, Issue:4

    Topics: Adolescent; Adult; Age Factors; Antipsychotic Agents; Child; Child Development Disorders, Pervasive; Humans; Naltrexone; Narcotic Antagonists; Risperidone; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Young Adult

2012
Pharmacotherapy for mental health problems in people with intellectual disability.
    Current opinion in psychiatry, 2016, Volume: 29, Issue:2

    Topics: Aggression; Anticonvulsants; Antipsychotic Agents; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Cognition; Human Growth Hormone; Humans; Intellectual Disability; Lithium Compounds; Mental Disorders; Methylphenidate; Naltrexone; Narcotic Antagonists; Prader-Willi Syndrome; Psychotropic Drugs; Risperidone

2016

Other Studies

13 other study(ies) available for naltrexone and risperidone

ArticleYear
QSAR model for drug human oral bioavailability.
    Journal of medicinal chemistry, 2000, Jun-29, Volume: 43, Issue:13

    Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship

2000
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
    Current drug discovery technologies, 2004, Volume: 1, Issue:4

    Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration

2004
Hologram QSAR model for the prediction of human oral bioavailability.
    Bioorganic & medicinal chemistry, 2007, Dec-15, Volume: 15, Issue:24

    Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship

2007
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
    Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7

    Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding

2008
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
    Journal of medicinal chemistry, 2008, Oct-09, Volume: 51, Issue:19

    Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship

2008
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Developing structure-activity relationships for the prediction of hepatotoxicity.
    Chemical research in toxicology, 2010, Jul-19, Volume: 23, Issue:7

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes

2010
A predictive ligand-based Bayesian model for human drug-induced liver injury.
    Drug metabolism and disposition: the biological fate of chemicals, 2010, Volume: 38, Issue:12

    Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands

2010
Experimental solubility profiling of marketed CNS drugs, exploring solubility limit of CNS discovery candidate.
    Bioorganic & medicinal chemistry letters, 2010, Dec-15, Volume: 20, Issue:24

    Topics: Central Nervous System Agents; Drug Evaluation, Preclinical; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Solubility

2010
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
    Drug metabolism and disposition: the biological fate of chemicals, 2012, Volume: 40, Issue:12

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship

2012
Which metabolites circulate?
    Drug metabolism and disposition: the biological fate of chemicals, 2013, Volume: 41, Issue:5

    Topics: Humans; Metabolic Clearance Rate; Pharmaceutical Preparations

2013
Effectiveness of naltrexone for treating pathologic skin picking behavior in an adolescent with Prader-Willi syndrome.
    Journal of child and adolescent psychopharmacology, 2012, Volume: 22, Issue:5

    Topics: Adolescent; Antipsychotic Agents; Behavior Therapy; Compulsive Behavior; Humans; Intellectual Disability; Male; Naltrexone; Narcotic Antagonists; Prader-Willi Syndrome; Psychotic Disorders; Risperidone

2012
Trichotillomania successfully treated with risperidone and naltrexone: a geriatric case report.
    Journal of the American Medical Directors Association, 2014, Volume: 15, Issue:4

    Topics: Aged, 80 and over; Antipsychotic Agents; Female; Humans; Naltrexone; Narcotic Antagonists; Risperidone; Trichotillomania

2014